Medication-overuse headache: Epidemiology, diagnosis and treatment

Therapeutic Advances in Drug Safety

Volumn 5, Issue 2, 2014, Pages 87-99

  Kristoffersen, Espen Saxhaug ^a,b   Lundqvist, Christofer ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

chronic headache; dependence; drug safety; medication overuse; migraine

Indexed keywords

ANALGESIC AGENT; ANTIEMETIC AGENT; CORTICOTROPIN RELEASING FACTOR; ENDOCANNABINOID; ERGOTAMINE; NON PRESCRIPTION DRUG; OREXIN A; PREDNISOLONE; SEROTONIN 2A RECEPTOR; STEROID; TRANQUILIZER; TRIPTAN DERIVATIVE;

ANXIETY; DEPRESSION; DETOXIFICATION; DIFFUSE NOXIOUS INHIBITORY CONTROL; DISEASE CLASSIFICATION; DRUG DEPENDENCE; DRUG INDUCED HEADACHE; DRUG SAFETY; EPISODIC MIGRAINE; FOLLOW UP; HEADACHE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; IDIOPATHIC DISEASE; LONG TERM EXPOSURE; MIGRAINE; ORBITAL CORTEX; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; REVIEW; SOCIAL PSYCHOLOGY; SOCIOECONOMICS; TENSION HEADACHE;

EID: 84899003904     PISSN: 20420986     EISSN: 20420994     Source Type: Journal    
DOI: 10.1177/2042098614522683     Document Type: Review

References (140)

1. Aaseth K. Grande R. Kvaerner K. Gulbrandsen P. Lundqvist C. Russell M. (2008) Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons. The Akershus Study of Chronic Headache. Cephalalgia 28: 705–713.
2. Abbott F. Fraser M. (1998) Use and abuse of over-the-counter analgesic agents. J Psychiatry Neurosci 23: 13–34.
3. Andrasik F. Grazzi L. Usai S. Kass S. Bussone G. (2010) Disability in chronic migraine with medication overuse: treatment effects through 5 years. Cephalalgia 30: 610–614.
4. Antonov K. Isacson D. (1998) Prescription and nonprescription analgesic use in Sweden. Ann Pharmacother 32: 485–494.
5. Atasoy H. Unal A. Atasoy N. Emre U. Sumer M. (2005) low income and education levels may cause medication overuse and chronicity in migraine patients. Headache 45: 25–31.
6. Aurora S. Dodick D. Turkel C. Degryse R. Silberstein S. Lipton R. (2010) Onabotulinumtoxina for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the Preempt 1 trial. Cephalalgia 30: 793–803.
7. Ayzenberg I. Obermann M. Nyhuis P. Gastpar M. Limmroth V. Diener H. (2006) Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia 26: 1106–1114.
8. Bahra A. Walsh M. Menon S. Goadsby P. (2003) Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 43: 179–190.
9. Bekkelund S. Salvesen R. (2002) Drug-associated headache is unrecognized in patients treated at a neurological centre. Acta Neurol Scand 105: 120–123.
10. Belanger S. Ma W. Chabot J. Quirion R. (2002) expression of calcitonin gene-related peptide, substance p and protein kinase c in cultured dorsal root ganglion neurons following chronic exposure to mu, delta and kappa opiates. Neuroscience 115: 441–453.
11. Bendtsen L. Evers S. Linde M. Mitsikostas D. Sandrini G. Schoenen J. (2010) EFNS guideline on the treatment of tension-type headache – report of an EFNS task force. Eur J Neurol 17: 1318–1325.
12. Bigal M. Lipton R. (2008) excessive acute migraine medication use and migraine progression. Neurology 71: 1821–1828.
13. Bigal M. Lipton R. (2009) overuse of acute migraine medications and migraine chronification. Curr Pain Headache Rep 13: 301–307.
14. Boe M. Mygland A. Salvesen R. (2007) prednisolone does not reduce withdrawal headache. Neurology 69: 26–31.
15. Boe M. Salvesen R. Mygland A. (2009a) Chronic daily headache with medication overuse: a randomized follow-up by neurologist or PCP. Cephalalgia 29: 855–863.
16. Boe M. Salvesen R. Mygland A. (2009b) Chronic daily headache with medication overuse: predictors of outcome 1 year after withdrawal therapy. Eur J Neurol 16: 705–712.
17. Bongsebandhu-Phubhakdi S. Srikiatkhachorn A. (2012) Pathophysiology of medication-overuse headache: implications from animal studies. Curr Pain Headache Rep 16: 110–115.
18. Calabresi P. Cupini L. (2005) Medication-overuse headache: similarities with drug addiction. Trends Pharmacol Sci 26: 62–68.
19. Castillo J. Munoz P. Guitera V. Pascual J. (1998) Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache 39: 190–196.
20. Cevoli S. Mochi M. Scapoli C. Marzocchi N. Pierangeli G. Pini L. (2006) A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. Eur J Neurol 13: 1009–1013.
21. Cevoli S. Sancisi E. Grimaldi D. Pierangeli G. Zanigni S. Nicodemo M. (2009) Family history for chronic headache and drug overuse as a risk factor for headache chronification. Headache 49: 412–418.
22. Colás R. Muñoz P. Temprano R. Gómez C. Pascual J. (2004) Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology 62: 1338–1342.
23. Cooper R. (2013a) ‘I can–t be an addict. I am.– Over-the-counter medicine abuse: a qualitative study. BMJ Open 3: e002913
24. Cooper R. (2013b) Over-the-counter medicine abuse – a review of the literature. J Subst Use 18: 82–107.
25. Creac–h C. Frappe P. Cancade M. Laurent B. Peyron R. Demarquay G. (2011) In-patient versus out-patient withdrawal programmes for medication overuse headache: a 2-year randomized trial. Cephalalgia 31: 1189–1198.
26. Cupini L. Costa C. Sarchielli P. Bari M. Battista N. Eusebi P. (2008) Degradation of endocannabinoids in chronic migraine and medication overuse headache. Neurobiol Dis 30: 186–189.
27. Cupini L. Sarchielli P. Calabresi P. (2010) Medication overuse headache: neurobiological, behavioural and therapeutic aspects. Pain 150: 222–224.
28. De Felice M. Ossipov M. Wang R. Lai J. Chichorro J. Meng I. (2010) Triptan-induced latent sensitization: a possible basis for medication overuse headache. Ann Neurol 67: 325–337.
29. Di Lorenzo C. Di Lorenzo G. Sances G. Ghiotto N. Guaschino E. Grieco G. (2009) Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism. J Headache Pain 10: 349–355.
30. Di Lorenzo C. Sances G. Di Lorenzo G. Rengo C. Ghiotto N. Guaschino E. (2007) The Wolframin His611Arg polymorphism influences medication overuse headache. Neurosci Lett 424: 179–184.
31. Diener H. (2012) Detoxification for medication overuse headache is not necessary. Cephalalgia 32: 423–427.
32. Diener H. Bussone G. Van Oene J. Lahaye M. Schwalen S. Goadsby P. (2007) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 27: 814–823.
33. Diener H. Dichgans J. Scholz E. Geiselhart S. Gerber W. Bille A. (1989) Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 236: 9–14.
34. Diener H. Dodick D. Aurora S. Turkel C. Degryse R. Lipton R. (2010) Onabotulinumtoxina for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the Preempt 2 trial. Cephalalgia 30: 804–814.
35. Diener H. Dodick D. Goadsby P. Bigal M. Bussone G. Silberstein S. (2009) Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia 29: 1021–1027.
36. Diener H. Limmroth V. (2004) Medication-overuse headache: a worldwide problem. Lancet Neurol 3: 475–483.
37. Dodick D. (2002) Debate: Analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is not a cause of chronic daily headache. Headache 42: 547–554.
38. Dodick D. Turkel C. Degryse R. Aurora S. Silberstein S. Lipton R. (2010) Onabotulinumtoxina for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the Preempt Clinical Program. Headache 50: 921–936.
39. Dyb G. Holmen T. Zwart J. (2006) Analgesic overuse among adolescents with headache: The Head-Hunt-Youth Study. Neurology 66: 198–210.
40. Eggen A. (1993) The Tromso Study: frequency and predicting factors of analgesic drug use in a free-living population (12-56 years). J Clin Epidemiol 46: 1297–1304.
41. Evers S. Afra J. Frese A. Goadsby P. Linde M. May A. (2009) EFNS Guideline on the drug treatment of migraine – revised report of an EFNS task force. Eur J Neurol 16: 968–981.
42. Evers S. Jensen R. (2011) treatment of medication overuse headache – guideline of the EFNS Headache Panel. Eur J Neurol 18: 1115–1121.
43. Evers S. Marziniak M. (2010) Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol 9: 391–401.
44. Ferrari A. Cicero A. Bertolini A. Leone S. Pasciullo G. Sternieri E. (2006) Need for analgesics/drugs of abuse: a comparison between headache patients and addicts by the Leeds Dependence Questionnaire (LDQ). Cephalalgia 26: 187–193.
45. Ferraro S. Grazzi L. Muffatti R. Nava S. Ghielmetti F. Bertolino N. (2012) In medication-overuse headache, FMRI shows long-lasting dysfunction in midbrain areas. Headache 52: 1520–1534.
46. Fritsche G. Frettloh J. Huppe M. Dlugaj M. Matatko N. Gaul C. (2010) Prevention of medication overuse in patients with migraine. Pain 151: 404–413.
47. Fuh J. Wang S. (2012) Dependent behavior in patients with medication-overuse headache. Curr Pain Headache Rep 16: 73–79.
48. Fuh J. Wang S. Lu S. Juang K. (2005) Does medication overuse headache represent a behavior of dependence? Pain 119: 49–55.
49. Fumal A. Laureys S. Di Clemente L. Boly M. Bohotin V. Vandenheede M. (2006) Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 129: 543–550.
50. Gaul C. Bromstrup J. Fritsche G. Diener H. Katsarava Z. (2011) Evaluating integrated headache care: a one-year follow-up observational study in patients treated at the Essen Headache Centre. BMC Neurol 11: 124.
51. Ghiotto N. Sances G. Galli F. Tassorelli C. Guaschino E. Sandrini G. (2009) Medication overuse headache and applicability of the ichd-ii diagnostic criteria: 1-year follow-up study (Care I Protocol). Cephalalgia 29: 233–243.
52. Gossop M. Darke S. Griffiths P. Hando J. Powis B. Hall W. (1995) The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 90: 607–614.
53. Grande R. Aaseth K. Benth J. Gulbrandsen P. Russell M. Lundqvist C. (2009) The severity of dependence scale detects people with medication overuse: The Akershus Study of Chronic Headache. J Neurol Neurosurg Psychiatry 80: 784–789.
54. Grande R. Aaseth K. Benth J. Lundqvist C. Russell M. (2011) Reduction in Medication-overuse headache after short information. The Akershus Study of Chronic Headache. Eur J Neurol 18: 129–137.
55. Grande R. Aaseth K. Gulbrandsen P. Lundqvist C. Russell M. (2008) Prevalence of primary chronic headache in a population-based sample of 30- to 44-year-old persons. The Akershus Study of Chronic Headache. Neuroepidemiology 30: 76–83.
56. Grazzi L. Andrasik F. D–amico D. Usai S. Kass S. Bussone G. (2004) Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up. Headache 44: 678–683.
57. Grazzi L. Andrasik F. Usai S. Bussone G. (2008) In-patient versus day-hospital Withdrawal treatment for chronic migraine with medication overuse and disability assessment: results at one-year follow-up. Neurol Sci 29 Suppl 1: S161–S163.
58. Grazzi L. Bussone G. (2012) Medication overuse headache (MOH): complication of migraine or secondary headache? Neurol Sci 33 Suppl 1: S27–28.
59. Hagen K. Jensen R. Boe M. Stovner L. (2010) Medication overuse headache: a critical review of end points in recent follow-up studies. J Headache Pain 11: 373–377.
60. Hagen K. Linde M. Steiner T. Stovner L. Zwart J. (2012) Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trøndelag Health Studies. Pain 153: 56–61.
61. Hagen K. Vatten L. Stovner L. Zwart J. Krokstad S. Bovim G. (2002) Low Socio-economic status is associated with increased risk of frequent headache: a prospective study of 22718 adults in Norway. Cephalalgia 22: 672–679.
62. Hargreave M. Andersen T. Nielsen A. Munk C. Liaw K. Kjaer S. (2010) Factors associated with a continuous regular analgesic use – a population-based study of more than 45,000 Danish women and men 18-45 years of age. Pharmacoepidemiol Drug Saf 19: 65–74.
63. Headache Classification Committee of the International Headache Society (IHS) (2013) The International Classification of Headache Disorders, 3rd Edition (beta version). Cephalalgia 33: 629–808.
64. Horton B. Peters G. (1963) Clinical manifestations of excessive use of ergotamine preparations and mangement of withdrawal effect: report of 52 cases. Headache 2: 214–227.
65. Jensen R. Stovner L. (2008) Epidemiology and comorbidity of headache. Lancet Neurol 7: 354–361.
66. Jonsson P. Hedenrud T. Linde M. (2011) Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia 31: 1015–1022.
67. Jonsson P. Linde M. Hensing G. Hedenrud T. (2012) Sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication-overuse headache. J Headache Pain 13: 281–290.
68. Katsarava Z. Fritsche G. Muessig M. Diener H. Limmroth V. (2001) Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 57: 1694–1698.
69. Katsarava Z. Jensen R. (2007) Medication-overuse headache: where are we now? Curr Opin Neurol 20: 326–330.
70. Katsarava Z. Limmroth V. Finke M. Diener H. Fritsche G. (2003) Rates and predictors for relapse in medication overuse headache: a 1-year prospective Study. Neurology 60: 1682–1683.
71. Katsarava Z. Muessig M. Dzagnidze A. Fritsche G. Diener H. Limmroth V. (2005) Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia 25: 12–15.
72. Katsarava Z. Obermann M. (2013) Medication-overuse headache. Curr Opin Neurol 26: 276–81.
73. Kristoffersen E. Grande R. Aaseth K. Lundqvist C. Russell M. (2012a) Management of primary chronic headache in the general population: the Akershus Study of Chronic Headache. J Headache Pain 13: 113–120.
74. Kristoffersen E. Lundqvist C. Aaseth K. Grande R. Russell M. (2013) Management of secondary chronic headache in the general population: the Akershus Study of Chronic Headache. J Headache Pain 14: 5.
75. Kristoffersen E. Straand J. Benth J. Russell M. Lundqvist C. (2012b) Study Protocol: brief intervention for medication overuse headache – a double-blinded cluster randomised parallel controlled trial in primary care. BMC Neurol 12: 70.
76. Krymchantowski A. Moreira P. (2003) Out-patient detoxification in chronic migraine: comparison of strategies. Cephalalgia 23: 982–993.
77. Kudrow L. (1982) Paradoxical effects of frequent analgesic use. Adv Neurol 33: 335–341.
78. Lake A. III (2006) Medication overuse headache: biobehavioral issues and solutions. Headache 46 Suppl 3: S88–97.
79. Lantéri-Minet M. Auray J. El Hasnaoui A. Dartigues J. Duru G. Henry P. (2003) Prevalence and description of chronic daily headache in the general population in France. Pain 102: 143–149.
80. Lantéri-Minet M. Duru G. Mudge M. Cottrell S. (2011) Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. Cephalalgia 31: 837–850.
81. Latinovic R. Gulliford M. Ridsdale L. (2006) Headache and migraine in primary care: consultation, prescription, and referral rates in a large population. J Neurol Neurosurg Psychiatry 77: 385–387.
82. Lauwerier E. Paemeleire K. Van Damme S. Goubert L. Crombez G. (2011) Medication use in patients with migraine and medication-overuse headache: the role of problem-solving and attitudes about pain medication. Pain 152: 1334–1339.
83. Le Grand S. Supornsilpchai W. Saengjaroentham C. Srikiatkhachorn A. (2011) Serotonin depletion leads to cortical hyperexcitability and trigeminal nociceptive facilitation via the nitric oxide pathway. Headache 51: 1152–1160.
84. Limmroth V. Katsarava Z. Fritsche G. Przywara S. Diener H. (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59: 1011–1014.
85. Linde M. Gustavsson A. Stovner L. Steiner T. Barre J. Katsarava Z. (2012) The Cost of headache disorders in Europe: The Eurolight Project. Eur J Neurol 19: 703–711.
86. Linton-Dahlöf P. Linde M. Dahlöf C. (2000) Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study. Cephalalgia 20: 658–662.
87. Lu S. Fuh J. Chen W. Juang K. Wang S. (2001) Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia 21: 980–986.
88. Lundqvist C. Aaseth K. Grande R. Benth J. Russell M. (2010) The severity of dependence score correlates with medication overuse in persons with secondary chronic headaches. The Akershus Study of Chronic Headache. Pain 148: 487–491.
89. Lundqvist C. Benth J. Grande R. Aaseth K. Russell M. (2011) An adapted severity of dependence scale is valid for the detection of medication overuse: the Akershus Study of Chronic Headache. Eur J Neurol 18: 512–518.
90. Lundqvist C. Grande R. Aaseth K. Russell M. (2012) Dependence scores predict prognosis of medication overuse headache: a prospective cohort from the Akershus Study of Chronic Headache. Pain 153: 682–686.
91. Mathew N. Kurman R. Perez F. (1990) Drug induced refractory headache-clinical features and management. Headache 30: 634–638.
92. Mehuys E. Paemeleire K. Van Hees T. Christiaens T. Van Bortel L. Van Tongelen I. (2012) Self-medication of regular headache: a community pharmacy-based survey. Eur J Neurol 19: 1093–1099.
93. Meng I. Dodick D. Ossipov M. Porreca F. (2011) Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies. Cephalalgia 31: 851–860.
94. Meskunas C. Tepper S. Rapoport A. Sheftell F. Bigal M. (2006) Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache 46: 766–772.
95. Munksgaard S. Bendtsen L. Jensen R. (2012) Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: a comparison of two consecutive treatment methods in an open-label design. Cephalalgia 32: 834–844.
96. Munksgaard S. Bendtsen L. Jensen R. (2013) Modulation of central sensitisation by detoxification in moh: results of a 12-month detoxification study. Cephalalgia:
97. Olesen J. (2012) Detoxification for medication overuse headache is the primary task. Cephalalgia 32: 420–422.
98. Paemeleire K. Bahra A. Evers S. Matharu M. Goadsby P. (2006) Medication-overuse headache in patients with cluster headache. Neurology 67: 109–113.
99. Patterson V. Esmonde T. (1993) Comparison of the handling of neurological outpatient referrals by general physicians and a neurologist. J Neurol Neurosurg Psychiatry 56: 830–830.
100. Perrotta A. Serrao M. Sandrini G. Burstein R. Sances G. Rossi P. (2010) Sensitisation of spinal cord pain processing in medication overuse headache involves supraspinal pain control. Cephalalgia 30: 272–284.
101. Peters G. Horton B. (1950) Headache; with special reference to the excessive use of ergotamine tartrate and dihydroergotamine. J Lab Clin Med 36: 972–973.
102. Peters G. Horton B. (1951) Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Proc Staff Meet Mayo Clin 26: 153–161.
103. Porteous T. Bond C. Hannaford P. Sinclair H. (2005) How and why are non-prescription analgesics used in Scotland? Fam Pract 22: 78–85.
104. Rabe K. Pageler L. Gaul C. Lampl C. Kraya T. Foerderreuther S. (2013) Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study. Cephalalgia 33: 202–207.
105. Radat F. Creac–h C. Guegan-Massardier E. Mick G. Guy N. Fabre N. (2008) Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria. Headache 48: 1026-1036.
106. Radat F. Creac–h C. Swendsen J. Lafittau M. Irachabal S. Dousset V. (2005) Psychiatric comorbidity in the evolution from migraine to medication Overuse Headache. Cephalalgia 25: 519–522.
107. Radat F. Lanteri-Minet M. (2010) What is the role of dependence-related behavior in medication-overuse headache? Headache 50: 1597–1611.
108. Ridsdale L. Clark L. Dowson A. Goldstein L. Jenkins L. McCrone P. (2007) How do patients referred to neurologists for headache differ from those managed in primary care? Br J Gen Pract 57: 388–395.
109. Rossi C. Pini L. Cupini M. Calabresi P. Sarchielli P. (2008a) Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels. Eur J Clin Pharmacol 64: 1–8.
110. Rossi P. Di L. Faroni J. Cesarino F. Nappi G. Di Lorenzo C. (2006) Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia 26: 1097–1105.
111. Rossi P. Faroni J. Nappi G. (2008b) Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study. Cephalalgia 28: 1196–1200.
112. Rossi P. Faroni J. Nappi G. (2011) Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache. Eur J Neurol 18: 396–401.
113. Rossi P. Faroni J. Tassorelli C. Nappi G. (2013) Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial. J Headache Pain 14: 10.
114. Rossi P. Jensen R. Nappi G. Allena M. Consortium C. (2009) A narrative review on the management of medication overuse headache: the steep road from experience to evidence. J Headache Pain 10: 407–417.
115. Russell M. Lundqvist C. (2012) Prevention and management of medication overuse headache. Curr Opin Neurol 25: 290–295.
116. Sandrini G. Perrotta A. Tassorelli C. Torelli P. Brighina F. Sances G. (2011) Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study. J Headache Pain 12: 427–433.
117. Saper J. Hamel R. Lake A. III (2005) Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia 25: 545–546.
118. Saper J. Lake A. III (2006) Medication overuse headache: type I and type II. Cephalalgia 26: 1262.
119. Sarchielli P. Rainero I. Coppola F. Rossi C. Mancini M. Pinessi L. (2008) Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid. Cephalalgia 28: 714–722.
120. Scher A. Lipton R. Stewart W. Bigal M. (2010) Patterns of medication use by chronic and episodic headache sufferers in the general population: results from the Frequent Headache Epidemiology Study. Cephalalgia 30: 321–328.
121. Srikiatkhachorn A. Anthony M. (2006) Serotonin receptor adaptation in patients with analgesic-induced headache. Cephalalgia 16: 419–422.
122. Srikiatkhachorn A. Maneesri S. Govitrapong P. Kasantikul V. (1998) Derangement of serotonin system in migrainous patients with analgesic abuse headache: clues from platelets. Headache 38: 43–49.
123. Stovner L. Hagen K. Jensen R. Katsarava Z. Lipton R. Scher A. (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27: 193–210.
124. Straube A. Pfaffenrath V. Ladwig K. Meisinger C. Hoffmann W. Fendrich K. (2010) Prevalence of chronic migraine and medication overuse headache in Germany – the German DMKG Headache Study. Cephalalgia 30: 207–213.
125. Sun-Edelstein C. Bigal M. Rapoport A. (2009) Chronic migraine and medication overuse headache: clarifying the Current International Headache Society classification criteria. Cephalalgia 29: 445–452.
126. Supornsilpchai W. Le Grand S. Srikiatkhachorn A. (2010a) Cortical hyperexcitability and mechanism of medication-overuse headache. Cephalalgia 30: 1101–1109.
127. Supornsilpchai W. Le Grand S. Srikiatkhachorn A. (2010b) Involvement of pro-nociceptive 5-HT2a receptor in the pathogenesis of medication-overuse headache. Headache 50: 185–197.
128. Supornsilpchai W. Sanguanrangsirikul S. Maneesri S. Srikiatkhachorn A. (2006) Serotonin depletion, cortical spreading depression, and trigeminal nociception. Headache 46: 34–39.
129. Tepper S. (2002) Debate: Analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is a cause of chronic daily headache. Headache 42: 543–547.
130. Vos T. Flaxman A. Naghavi M. Lozano R. Michaud C. Ezzati M. (2012) Years lived with disability (YLDS) for 1160 sequelae of 289 diseases and injuries 1990-2010: A Systematic Analysis for the Global Burden of Disease Study 2010. Lancet 380: 2163–2196.
131. Wang S. Fuh J. Lu S. Juang K. (2006) Chronic daily headache in adolescents: prevalence, impact, and medication overuse. Neurology 66: 193–197.
132. Wang S. Fuh J. Lu S. Liu C. Hsu L. Wang P. (2000) Chronic daily headache in chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology 54: 314–319.
133. Wiendels N. Knuistingh Neven A. Rosendaal F. Spinhoven P. Zitman F. Assendelft W. (2006) Chronic frequent headache in the general population: prevalence and associated factors. Cephalalgia 26: 1434–1442.
134. Wilkinson S. Becker W. Heine J. (2001) Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 41: 303–309.
135. Zeeberg P. Olesen J. Jensen R. (2006a) Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 26: 1192–1198.
136. Zeeberg P. Olesen J. Jensen R. (2006b) Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 66: 1894–1898.
137. Zidverc-Trajkovic J. Pekmezovic T. Jovanovic Z. Pavlovic A. Mijajlovic M. Radojicic A. (2007) Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up. Cephalalgia 27: 1219–1225.
138. Zwart J. Dyb G. Hagen K. Ødegärd K. Dahl A. Bovim G. (2003a) Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Health Study. Eur J Neurol 10: 147–152.
139. Zwart J. Dyb G. Hagen K. Svebak S. Holmen J. Head T. (2003b) Analgesic use: a predictor of chronic pain and medication overuse headache. Neurology 61: 160–164.
140. Zwart J. Dyb G. Hagen K. Svebak S. Stovner L. Holmen J. (2004) Analgesic overuse among subjects with headache, neck, and low-back pain. Neurology 62: 1540–1544.